BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research note published on Sunday morning. The firm issued a sell rating on the medical technology company’s stock.

BIOLASE Stock Performance

Shares of BIOLASE stock opened at $0.01 on Friday. The firm has a market cap of $330,729.30, a PE ratio of 0.00 and a beta of 0.67. The stock has a 50 day moving average of $0.01 and a 200 day moving average of $0.02. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.